Immunoreactive endomorphin 2 is generated extracellularly in rat isolated L4,5 dorsal root ganglia by DPP-IV

Regulatory Peptides

Volumn 157, Issue 1-3, 2009, Pages 1-2

  Rónai, András Z ^a   Király, Kornél ^a   Szebeni, Andrea ^a   Szemenyei, Erzsébet ^b   Prohászka, Zoltán ^c   Darula, Zsuzsanna ^b   Tóth, Géza ^b   Till, Ibolya ^d   Szalay, Balázs ^a   Kató, Erzsébet ^a   Barna, István ^d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF BIOCHEMISTRY   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Dipeptidyl peptidase IV; Endomorphin 2 biosynthesis; Ile Pro Ile (Diprotin A); Tyr Pro precursor

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; DIPROTIN A; ENDOMORPHIN 2; PROTEIN PRECURSOR; SUBSTANCE P; TYROSYLPROLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DEPOLARIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; SPINAL GANGLION; TISSUE LEVEL;

ANIMALS; ANTIGENS, CD26; CELL MEMBRANE; GANGLIA, SPINAL; OLIGOPEPTIDES; PILOT PROJECTS; RATS;

RATTUS;

EID: 68349090358     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.06.006     Document Type: Article

References (19)

1. Zadina J.E., Hackler L., Ge L.-J., and Kastin A.J. A potent and selective endogenous agonist forthe μ-opiate receptor. Nature 386 (1997) 499-502
2. Horvath G. Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous μ-opioid receptor agonists. Pharmacol. Ther. 88 (2000) 437-463
3. Alt A., Mansour A., Akil H., Medzihradsky F., Traynor J.R., and Woods J.H. Stimulation ofguanosine-5′-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at acloned mu receptor. J. Pharmacol. Exp. Ther. 286 (1998) 282-288
4. Przewlocki R., and Przewlocka B. Opioids in chronic pain. Eur. J. Pharmacol. 429 (2001) 79-91
5. Wilson A.M., Soignier R.D., Zadina J.E., Kastin A.J., Nores W.L., Olson R.D., and Olson G.A. Dissociation of analgesic and rewarding effects of endomorphin-1 in rats. Peptides 21 (2000) 1871-1874
6. Czapla M.A., Gozal D., Alea O.A., Beckerman R.C., and Zadina J.E. Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO and morphine. Am. J. Respir. Crit. Care Med. 162 (2000) 994-999
7. Fichna J., Janecka A., Costentin J., and Do Rego J.-C. The endomorphin system and its evolvingneurophysiological role. Pharmacol. Rev. 59 (2007) 88-123
8. Wolfe D., Hao S., Hu J., Srinivasan R., Goss J., Mata M., Fink D.J., and Glorioso J.C. Engineering an endomorphin-2 gene for use in neuropathic pain therapy. Pain 133 (2007) 29-38
9. Terskiy A., Wannemacher K.M., Yadav P.N., Tsai M., Tian B., and Howells R.D. Search of thehuman proteome for endomorphin-1 and endomorphin-2 precursor proteins. Life Sci. 81 (2007) 1593-1601
10. Martin-Schild S., Zadina J.E., Gerall A.A., Vigh S., and Kastin A.J. Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. Peptides 18 (1997) 1641-1649
11. Pierce T.L., and Wessendorf M.W. Immunocytochemical mapping of endomorphin-2immunoreactivity in rat brain. J. Chem. Neuroanat. 18 (2000) 181-207
12. Lisi T.L., and Sluka K.A. A new electrochemical HPLC method for analysis ofenkephalins and endomorphins. J. Neurosci. Methods 150 (2006) 74-79
13. Scanlin H.L., Carroll E.A., Jenkins V.K., and Balkowiec A. Endomorphin-2 is released from newborn rat primary sensory neurons in a frequency- and calcium-dependent manner. Eur. J. Neurosci. 27 (2008) 2629-2642
14. 3H]-Tyr-Pro: a possible biosynthetic route for endomorphins. Reg. Pept. 134 (2006) 54-60
15. Sanderson Nydahl K., Skinner K., Julius D., and Basbaum A.I. Co-localization ofendomorphin-2 and substance P in primary afferent nociceptors and effects ofinjury: a light and electron microscopic study in the rat. Eur. J. Neurosci. 19 (2004) 1789-1799
16. Garland A., Necheles J., White S.R., Neeley S.P., Leff A.R., Carson S.S., Alger L.E., McAllister K., and Solway J. Activated eosinophils elicit substance P release from cultured dorsal root ganglion neurons. Am. J. Physiol. 273 (1997) L1096-L1102
17. Sun R.Q., Wang Y., Zhao C.S., Chang J.K., and Han J.S. Changes in brain content of nociceptin/orphanin FQ and endomorphin 2 in a rat model of neuropathic pain. Neurosci. Lett. 311 (2001) 13-16
18. Szemenyei E., Barna I., Mergl Z.S., Keresztes A., Darula Z.S., Kató E., Tóth G., and Rónai A.Z. Detection of a novel immunoreactive endomorphin 2-like peptide in rat brain extracts. Reg. Pept. 148 (2008) 54-61
19. Mentlein R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Reg. Pept. 85 (1999) 9-24